HomeQuestion

Do you use biomarkers to improve risk prediction in patients with ADPKD during early disease stages?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you temporarily hold ESAs for your patients with kidney disease who have an upcoming surgical procedure with the goal of reducing the risk for DVTs?

Would you recommend the use of an ACE inhibitor to patients with Type 1 diabetes mellitus who are normotensive but have persistent moderate proteinuria?

What is your hemoglobin target for patients with nondialysis chronic kidney disease who are receiving ESA therapy?

Under what circumstances would you consider a kidney biopsy in an HIV patient with subnephrotic range proteinuria, microscopic hematuria, and stable renal function who has been on a tenofovir-based regimen?

How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.